Hauv cov tshuaj niaj hnub no, cov tshuaj nucleic acid tau tshwm sim los ua cov cuab yeej muaj zog los kho ntau yam kab mob. Tsis zoo li cov tshuaj me me thiab cov tshuaj tiv thaiv kab mob, cov tshuaj nucleic acid kho ncaj qha rau cov khoom siv caj ces-RNA lossis DNA- muab txoj hauv kev tshiab los daws cov hom phiaj yav dhau los "tsis siv tau". Kab lus no qhia txog kev txhim kho kev nce qib ntawm cov tshuaj nucleic acid thiab qhia txog Prisys Biotech lub peev xwm hauv qhov kev txiav no - ntug.
Txheej txheem cej luam ntawm Nucleic Acid Drug Development
Cov tshuaj Nucleic acid tau ua kom muaj kev vam meej hauv xyoo tas los no, tshwj xeeb hauv kev kho mob plawv, metabolic, kab mob siab, thiab ntau yam kab mob tsawg. Cov tshuaj no ua haujlwm los ntawm kev hloov pauv lub hom phiaj protein RNA, kho RNA, lossis nthuav tawm cov protein ua haujlwm los ntawm nucleic acid vectors (DNA) lossis mRNA, muab kev kho tshiab.
Hom Novel Nucleic Acid Therapeutics
Cov tshuaj nucleic acid feem ntau suav nrog me me cuam tshuam RNA (siRNA), antisense oligonucleotides (ASOs), adeno-cov kab mob sib txuas (AAV) vectors, thiab mRNA. Cov molecules no siv cov txheej txheem sib txawv kom ua tiav cov txiaj ntsig kho mob, xws li RNA downregulation, RNA kho, lossis mRNA qhia, muab ntau txoj kev kho mob.
Preclinical Pharmacological Challenges
Txawm hais tias lawv muaj peev xwm kho tau, cov tshuaj nucleic acid ntsib ob qhov teeb meem tseem ceeb hauv cov kws kho mob preclinical: kev xa khoom thiab kev nyab xeeb. Muab lawv cov txheej txheem sib txawv piv rau cov tshuaj ib txwm siv, cov txheej txheem tshiab yuav tsum tau kov yeej cov teeb meem no.
Kev Sib Tw Kev Xa Tshuaj
- Targeted Delivery:Cov tshuaj nucleic acid yuav tsum raug xa mus rau cov hlwb tshwj xeeb lossis cov ntaub so ntswg kom ntseeg tau tias muaj txiaj ntsig thiab txo qis - cov teebmeem. Txawm li cas los xij, vim lawv cov qauv loj, tsis zoo them nqi, cov molecules no nyuaj hla cov cell membranes, thiab lawv qhov kev faib tawm hauv vivo tuaj yeem tsis sib xws.
- Zam Kev Ceev Ceev:Kev ruaj ntseg hauv vivo yog ib qho kev txhawj xeeb loj, vim tias cov tshuaj nucleic acid tuaj yeem degraded sai sai los ntawm nucleases, txo cov tshuaj concentration thiab kev ua tau zoo.
- Systemic Delivery:Kev faib tawm ntawm cov tshuaj nucleic acid nyob rau hauv lub cev yog cuam tshuam los ntawm yam xws li kev ncig, cellular uptake, thiab cov ntaub so ntswg nkag. Kev ua tiav kev xa khoom zoo, tshwj xeeb hauv cov qauv tsiaj loj, yuav tsum muaj cov tshuab xa khoom tshwj xeeb xws li liposomes, nanoparticles, lossis kab mob kab mob.
- Hla Biological Barriers:Cov kabmob xws li lub hlwb thiab lub qhov muag raug tiv thaiv los ntawm cov kab mob lom xws li cov ntshav - lub hlwb barrier thiab ntshav -retinal barrier, uas txwv tsis pub xa tshuaj. Kev tsim cov tshuab muaj peev xwm kov yeej cov teeb meem no yog qhov tseem ceeb rau kev kho cov kab mob hauv cov kab mob no.
Kev Ntsuam Xyuas Kev Nyab Xeeb Kev Sib Tw
- Immunogenicity thiab Immunotoxicity:Cov tshuaj nucleic acid tuaj yeem ua rau lub cev tiv thaiv kab mob, ua rau mob lossis lwm yam teebmeem. Kev soj ntsuam immunogenicity thiab cov tswv yim xws li kev hloov kho tshuaj lom neeg lossis kev siv cov tshuaj tiv thaiv kab mob kom txo tau cov tshuaj tiv thaiv kab mob yog qhov tseem ceeb ntawm kev tshawb fawb ua ntej.
- Tawm -Cov teebmeem:Vim yog qhov sib lawv liag -txheej txheem kev sib khi ntawm cov tshuaj nucleic acid, muaj peev xwm ua rau tawm - lub hom phiaj khi, ua rau muaj kev cuam tshuam tsis zoo rau kev lom neeg.
- koob tshuaj -Dependent Toxicity:Cov tshuaj toxicity ntawm cov tshuaj nucleic acid tuaj yeem yog koob tshuaj - cuam tshuam, nrog cov koob tshuaj ntau tuaj yeem ua rau cytotoxicity lossis cov ntaub so ntswg puas. Kev txiav txim siab qhov kev nyab xeeb thiab siv tau ntau npaum li cas yog qhov tseem ceeb ntawm cov kev tshawb fawb preclinical.
- Ntev - Lub Sij Hawm Stability thiab cumulative Toxicity:Ntev -lub sij hawm ruaj khov thiab muaj txiaj ntsig zoo ntawm cov tshuaj nucleic acid hauv lub cev xav tau kev soj ntsuam kom zoo los xyuas kom muaj kev nyab xeeb ntawm kev siv txuas ntxiv.
- Vector Safety:Rau cov tshuaj nucleic acid siv cov kab mob viral xws li AAV, ntsuas kev nyab xeeb ntawm vector nws tus kheej, suav nrog kev pheej hmoo ntawm kev nkag mus rau mutagenesis thiab tus tswv tsev tiv thaiv kab mob rau cov vector, yog qhov tseem ceeb.
Preclinical Research Strategies
Txhawm rau kov yeej cov teeb meem no, cov kws tshawb fawb siv ntau lub tswv yim:
- Kev hloov kho tshuaj:Kev hloov kho nucleic acid molecules, xws li ntxiv cov pab pawg tiv thaiv lossis siv cov nucleotides hloov kho, tuaj yeem txhim kho kev ruaj ntseg thiab txo kev tiv thaiv kab mob.
- Optimizing Delivery Systems:Tsim cov txheej txheem xa khoom siab, xws li lipid nanoparticles lossis cov khoom lipid nanoparticles, tuaj yeem txhim kho kev ua tau zoo thiab tshwj xeeb ntawm kev xa tshuaj nucleic acid.
- Immune Modulation:Siv cov tshuaj tiv thaiv kab mob lossis tsim kev tiv thaiv kab mob -cov tshuaj uas ntsiag to nucleic acid tuaj yeem pab txo qis kev tiv thaiv kab mob.
- Pharmacokinetic thiab Toxicology Studies:Ua kom paub meej cov kev tshawb fawb pharmacokinetic thiab toxicology yog qhov tseem ceeb rau kev soj ntsuam kev faib khoom, metabolism, kev tso tawm, thiab tshuaj lom ntawm cov tshuaj nucleic acid hauv vivo.
- Animal Model Studies:Kev soj ntsuam ntau ntawm cov tshuaj pharmacodynamic thiab kev nyab xeeb hauv cov qauv tsiaj yog ua los kwv yees cov txiaj ntsig kev kho mob thiab kev pheej hmoo.
Prisys Biotech's In Vivo Pharmacology Expertise
Prisys Biotech's in vivo pharmacology pab pawg tau tsim cov kws tshaj lij los kawm cov tshuaj pharmacodynamics thiab pharmacokinetics ntawm cov nucleic acid molecules tshiab hauvCentral paj hlwb (CNS), daim siab, qhov muag, pob ntseg, thiab lwm yam kabmob uas sivtsis yog-neeg primate (NHP) qauv. Qhov no suav nrog kev xa khoom hauv zos, hauv vivo sampling, thiab kev tshawb fawb duab. Prisys Biotech kuj tau tsim ib lub platform rau kev tshawb fawb hauv lub cev thiab hloov kho lub cev tiv thaiv kab mob, ua kom muaj kev ntsuam xyuas ua ntej ntawm cov tshuaj tiv thaiv kab mob thiab kev tiv thaiv kab mob ntawm oligonucleotides thiab AAV hauv cov tsiaj loj.
Case Studies
Prisys Biotech qhia tau hais tias tus qauv tsiaj tuaj yeem daws cov teeb meem pharmacological ntawm nucleic acid kho los ntawm ntau qhov kev tshawb fawb:
- Case 1: Intracerebroventricular (ICV) vs. Intrathecal (IT) TxhajCov kws tshawb fawb tau sib piv ob txoj kev xa khoom:ICV thiab IT txhaj tshuajntawm oligonucleotides. Kev txhaj tshuaj ICV tau pom tias muaj kev txo qis ntawm lub hom phiaj RNA hauv striatum, prefrontal cortex, thiab lub ncauj tsev menyuam txha caj qaum, tab sis muaj kev cuam tshuam tsis muaj zog ntawm dorsal cag ganglia. Hloov pauv, IT txhaj tshuaj tau ua tiav ntau dua kev tswj hwm hauv dorsal cag ganglia thiab lumbar qaum qaum, tab sis qis dua cov teebmeem hauv striatum thiab prefrontal cortex. Qhov kev sib piv no qhia txog qhov cuam tshuam ntawm txoj kev xa khoom sib txawv ntawm CNS kev faib tshuaj thiab kev ua tau zoo.
- Case 2: Targeted AAV Delivery and Safety in NHP Brains Prisys Biotech tau kuaj AAV cov tshuaj tiv thaiv kab mob hauv cynomolgus liab thiab xaiv cov tshuaj tiv thaiv kab mob -cov tsiaj tsis zoo rau lumbar IT txhaj. Qee cov tsiaj ua npaws thiab qaug dab peg tom qab kev tswj hwm, tab sis cov tsos mob tau daws tsis pub dhau 24 teev. Hauv kev sim tom ntej, ua ntej- kev tswj hwm ntawm cov tshuaj tiv thaiv kab mob ua tiav tiv thaiv cov kev mob tshwm sim no, muab kev nkag siab txog kev tswj cov tshuaj tiv thaiv kab mob thaum lub sij hawm kho AAV.
- Case 3: Oligonucleotide Efficacy nyob rau hauv Tsiaj QauvHauv kev tshawb fawb ntev -, kev ua tau zoo ntawm oligonucleotide tau sim hauv cov qauv tsiaj transgenic nrog tus kab mob- cuam tshuam txog kev hloov pauv noob. Tom qab ob koob tshuaj, cov kws tshawb fawb tau saib xyuas kev ciaj sia, lub cev hnyav, cov qhab nia kho mob, thiab lub cev muaj zog. Tsiaj txhu kho nrog oligonucleotides tsis pom kev tuag, qhov hnyav nce ntxiv, thiab cov tsos mob tsawg, thaum cov tsiaj tswj tau pom qhov hnyav hnyav, cov tsos mob ntawm lub paj hlwb, thiab ntau dua 50% kev tuag thaum kawg ntawm txoj kev tshawb no. Cov txiaj ntsig no tau lees paub qhov kev kho mob ntawm oligonucleotides hauv cov qauv no.
Prisys Biotech's Preclinical In Vivo Pharmacology Platform
Prisys Biotech's in vivo pharmacology platform tau txais kev txhawb nqa los ntawm cov kws tshaj lij kev tswj hwm thiab pab pawg kws tshaj lij nrog kev paub dav dav hauv thaj chaw muaj kab mob. Lub platform tau nruab los muab cov kev pabcuam kws tshuaj thiab kev ntsuas kev ua tau zoo thoob plaws txhua qhov chaw kab mob loj, txhawb nqa ntau yam tsiaj qauv thiab kev sim tshuaj ua tau zoo.
Txoj kev loj hlob ntawm cov tshuaj nucleic acid yog ob qho tib si nyuaj thiab muaj kev vam meej. Nrog nws cov kev tshawb fawb muaj zog thiab pab pawg kws tshaj lij, Prisys Biotech tau dhau los ua tus thawj coj hauv qhov chaw no. Peb tos ntsoov rau Prisys Biotech qhov kev hloov tshiab txuas ntxiv hauv kev txhim kho kho, muab kev cia siab tshiab rau cov neeg mob thoob ntiaj teb.
